ACHC — Acadia Healthcare Cashflow Statement
0.000.00%
Last trade - 00:00
- $6.39bn
- $8.28bn
- $2.93bn
- 71
- 51
- 64
- 66
R2019 December 31st | 2020 December 31st | C2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 110 | -669 | 196 | 280 | -15.7 |
Depreciation | |||||
Deferred Taxes | |||||
Non-Cash Items | 128 | 941 | 104 | 35.6 | 433 |
Discontinued Operations | |||||
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -19.3 | 163 | -43.5 | -69.4 | 6.63 |
Change in Accounts Receivable | |||||
Change in Other Assets | |||||
Change in Accrued Expenses | |||||
Change in Other Liabilities | |||||
Net Change in Other Assets & Liabilities | |||||
Cash from Operating Activities | 308 | 584 | 374 | 381 | 462 |
Capital Expenditures | -233 | -225 | -245 | -296 | -424 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | 31.5 | -56.9 | 1,258 | -9.68 | 26.9 |
Acquisition of Business | |||||
Sale of Business | |||||
Sale of Fixed Assets | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -201 | -282 | 1,013 | -306 | -397 |
Financing Cash Flow Items | -8.64 | -25.6 | 4.38 | 2.69 | -46.4 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -61.6 | -51.5 | -1,637 | -111 | -62.7 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 49 | 255 | -245 | -36.2 | 2.42 |